Report from Extraordinary General Meeting in LIDDS
UPPSALA, SWEDEN – LIDDS AB (publ)’s (“LIDDS” or the “Company”) Extraordinary General Meeting was held 11 March 2022 in the Company’s premises in Uppsala. The Extraordinary General Meetin...
- Supported exchanges /
- ST /
- LIDDS.ST
Lidds AB (LIDDS ST) stock market data APIs
kr-0.226
-0.35(-292.9%)
as of November 22, 2024
Price chart is built with Anychart
LIDDS AB (publ), a drug delivery company, develops pharmaceutical products based on its NanoZolid proprietary technology for the treatment of cancer and other diseases in Sweden. The company's oncology pipeline in clinical development includes Liproca Depot, a NanoZolid-formulated 2-hydroxyltutamide (2-HOF), which is an anti-androgen drug that binds and blocks androgen receptors; Nanodotax, a NanoZolid-formulated docetaxel, which is a chemotherapy medication that is approved for various oncological conditions, such as breast cancer, head and neck cancer, and prostate cancer; and Nanoimod, a NanoZolid-formulated agatolimod, which is a toll-like receptor 9 (TLR9) agonist. The company was founded in 2003 and is based in Uppsala, Sweden.
Lidds AB Financial Data Overview
| 0.3395 | |
| -0.226 | |
| - | |
| 0.224 | |
| 0.3905 | |
| 0.082-0.37 | |
| 18 354 K | |
| 136 M | |
| 17 000 | |
| 0.185 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'LIDDS',
Type:
'Common Stock',
Name:
'Lidds AB',
Exchange:
'ST',
CurrencyCode:
'SEK',
CurrencyName:
'Swedish krone',
CurrencySymbol:
'kr',
CountryName:
'Sweden',
CountryISO:
'SE',
OpenFigi:
NULL,
ISIN:
'SE0001958612',
CIK:
NULL,
EmployerIdNumber:
'',
FiscalYearEnd:
'December',
IPODate:
NULL,
InternationalDomestic:
'International',
Sector:
'Healthcare',
Industry:
'Biotechnology',
}
Lidds AB Fundamental Data is available in our Financial Data APIs
- Net Revenue 17 000
- EBITDA -25 637 000
- Earnings Per Share -0.37
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Lidds AB Earnings via APIs
- Latest Release 2024-11-21
- EPS/Forecast NaN
Get Lidds AB End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Get Lidds AB latest news via APIs
LIDDS publishes agenda for the company's Capital Markets Day 2022
UPPSALA, SWEDEN – LIDDS AB (publ) announced today the agenda for the Capital Markets Day to be held on March 9, 2022, for investors, analysts and media. Agenda Capital Markets Day 2022 15.00-15.10...
- COMPANY ANNOUNCEMENT
- LIDDS AB
- STOCKHOLM STOCK EXCHANGE:LIDDS
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
